Michael F. Pehl - Net Worth and Insider Trading

Michael F. Pehl Net Worth

The estimated net worth of Michael F. Pehl is at least $0 dollars as of 2024-04-27. Michael F. Pehl is the See remarks of Celgene Corp and owns about 0 shares of Celgene Corp (CELG) stock worth over $0. Details can be seen in Michael F. Pehl's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael F. Pehl has not made any transactions after 2016-11-10 and currently still holds the listed stock(s).

Transaction Summary of Michael F. Pehl

Michael F. Pehl Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael F. Pehl owns 1 companies in total, including Immunomedics Inc (IMMU) .

Click here to see the complete history of Michael F. Pehl’s form 4 insider trades.

Insider Ownership Summary of Michael F. Pehl

Ticker	Comapny	Transaction Date	Type of Owner
IMMU	Immunomedics Inc	2018-09-14	President and CEO

Michael F. Pehl Latest Holdings Summary

Michael F. Pehl currently owns a total of 1 stock. Michael F. Pehl owns 0 shares of Celgene Corp (CELG) as of November 10, 2016, with a value of $0.

Latest Holdings of Michael F. Pehl

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CELG	Celgene Corp	2016-11-10	0	108.24	0

Holding Weightings of Michael F. Pehl

Michael F. Pehl Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael F. Pehl has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 22,052 shares on November 10, 2016, which brought Michael F. Pehl around $3 Million.

Insider Trading History of Michael F. Pehl

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael F. Pehl Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael F. Pehl Ownership Network

Ownership Network List of Michael F. Pehl

No Data

Ownership Network Relation of Michael F. Pehl

Michael F. Pehl Owned Company Details

What does Immunomedics Inc do?

Who are the key executives at Immunomedics Inc?

Michael F. Pehl is the President and CEO of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .

Immunomedics Inc (IMMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunomedics Inc Insider Transactions

No Available Data

Michael F. Pehl Mailing Address

Above is the net worth, insider trading, and ownership report for Michael F. Pehl. You might contact Michael F. Pehl via mailing address: C/o Celgene Corporation 86 Morris Avenue Summit Nj 07901.

Discussions on Michael F. Pehl

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.